KIMBERLY QUIRING: Open Payments
NPI 1689675522 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,896 in 174 payments from 23 companies in 2025. Trend: 2023 $1,651 · 2024 $2,822 · 2025 $3,896
Food & beverage: $3,896
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $653 |
| ARGENX US, INC. | 12 | $346 |
| UCB, Inc. | 18 | $275 |
| Teva Pharmaceuticals USA, Inc. | 11 | $268 |
| Eisai Inc. | 10 | $245 |
| Alexion Pharmaceuticals, Inc. | 8 | $224 |
| Novartis Pharmaceuticals Corporation | 9 | $218 |
| Lundbeck LLC | 12 | $216 |
| PFIZER INC. | 11 | $198 |
| ACADIA Pharmaceuticals Inc | 8 | $190 |
Products named: VYVGART HYTRULO, AUSTEDO XR, Leqembi, ULTOMIRIS, KESIMPTA, QULIPTA, NURTEC ODT, BOTOX.
Industry payments across AZ — which companies pay providers there.
